Global Therapeutic Nuclear Medicines Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.

Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Therapeutic Nuclear Medicines market is projected to reach US$ 5392 million by 2028 from an estimated US$ 1997.4 million in 2022, at a CAGR of 18.0% during 2023 and 2028.

Global Therapeutic Nuclear Medicines key players include Bayer, Novartis AG, China Isotope & Radiation, etc. Global top three manufacturers hold a share over 75%.

North America is the largest market, with a share about 45%, followed by Europe and Asia-Pacific, both have a share about 50 percent.

In terms of product, Radium-223 is the largest segment, with a share over 45%. And in terms of application, the largest application is Thyroid, followed by Bone Metastasis.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Therapeutic Nuclear Medicines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Therapeutic Nuclear Medicines.

The Therapeutic Nuclear Medicines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Therapeutic Nuclear Medicines market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Therapeutic Nuclear Medicines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Novartis AG

Bayer

China Isotope & Radiation

Q BioMed

Curium Pharmaceuticals

Jubilant DraxImage

Dongcheng

Lantheus

Acrotech Biopharma.

Progenics Pharmaceuticals

International Isotopes

Product Type Insights

Global markets are presented by Therapeutic Nuclear Medicines type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Therapeutic Nuclear Medicines are procured by the manufacturers.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Radium-223

Lutetium-177

Iodine-131

Other

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Therapeutic Nuclear Medicines market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Therapeutic Nuclear Medicines market.

Thyroid

Bone Metastasis

Lymphoma

Other

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia-Pacific

China

Japan

South Korea

India

Southeast Asia

Australia

Rest of Asia-Pacific

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Therapeutic Nuclear Medicines market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Therapeutic Nuclear Medicines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Therapeutic Nuclear Medicines and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Therapeutic Nuclear Medicines industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Therapeutic Nuclear Medicines

1.1 Therapeutic Nuclear Medicines Product Introduction

1.2 Market by Type

1.2.1 Global Therapeutic Nuclear Medicines Market Size Growth Rate by Type (2017 VS 2021 VS 2028)

1.2.2 Radium-223

1.2.3 Lutetium-177

1.2.4 Iodine-131

1.2.5 Other

1.3 Market by Application

1.3.1 Global Therapeutic Nuclear Medicines Market Size Growth Rate by Application (2017 VS 2021 VS 2028)

1.3.2 Thyroid

1.3.3 Bone Metastasis

1.3.4 Lymphoma

1.3.5 Other

1.4 Study Objectives

1.5 Years Considered

2.1 Global Therapeutic Nuclear Medicines Market Size Estimates and Forecasts

2.1.1 Global Therapeutic Nuclear Medicines Revenue 2017-2028

2.1.2 Global Therapeutic Nuclear Medicines Sales 2017-2028

2.2 Therapeutic Nuclear Medicines Market Size by Region: 2022 Versus 2028

2.3 Therapeutic Nuclear Medicines Sales by Region (2017-2028)

2.3.1 Global Therapeutic Nuclear Medicines Sales by Region: 2017-2022

2.3.2 Global Therapeutic Nuclear Medicines Sales Forecast by Region (2023-2028)

2.3.3 Global Therapeutic Nuclear Medicines Sales Market Share by Region (2017-2028)

2.4 Therapeutic Nuclear Medicines Market Estimates and Projections by Region (2023-2028)

2.4.1 Global Therapeutic Nuclear Medicines Revenue by Region: 2017-2022

2.4.2 Global Therapeutic Nuclear Medicines Revenue Forecast by Region (2023-2028)

2.4.3 Global Therapeutic Nuclear Medicines Revenue Market Share by Region (2017-2028)

3.1 Global Top Therapeutic Nuclear Medicines Manufacturers by Sales

3.1.1 Global Therapeutic Nuclear Medicines Sales by Manufacturer (2017-2022)

3.1.2 Global Therapeutic Nuclear Medicines Sales Market Share by Manufacturer (2017-2022)

3.2 Global Top Therapeutic Nuclear Medicines Manufacturers by Revenue

3.2.1 Global Therapeutic Nuclear Medicines Revenue by Manufacturer (2017-2022)

3.2.2 Global Therapeutic Nuclear Medicines Revenue Share by Manufacturer (2017-2022)

3.3 Global Therapeutic Nuclear Medicines Price by Manufacturer (2017-2022)

3.4 Competitive Landscape

3.4.1 Key Therapeutic Nuclear Medicines Manufacturers Covered: Ranking by Revenue

3.4.2 Global Therapeutic Nuclear Medicines Market Concentration Ratio (CR5 and HHI) & (2017-2022)

3.4.3 Global Therapeutic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.5 Global Therapeutic Nuclear Medicines Manufacturing Base Distribution, Product Type

3.5.1 Therapeutic Nuclear Medicines Manufacturers Manufacturing Base Distribution, Headquarters

3.5.2 Manufacturers Therapeutic Nuclear Medicines Product Type

3.5.3 Date of International Manufacturers Enter into Therapeutic Nuclear Medicines Market

3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4.1 Novartis AG

4.1.1 Novartis AG Corporation Information

4.1.2 Novartis AG Description, Business Overview

4.1.3 Novartis AG Therapeutic Nuclear Medicines Products Offered

4.1.4 Novartis AG Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2017-2022)

4.1.5 Novartis AG Therapeutic Nuclear Medicines Sales by Product in 2021

4.1.6 Novartis AG Therapeutic Nuclear Medicines Sales by Application in 2021

4.1.7 Novartis AG Therapeutic Nuclear Medicines Sales by Geographic Area in 2021

4.1.8 Novartis AG Recent Developments

4.2 Bayer

4.2.1 Bayer Corporation Information

4.2.2 Bayer Description, Business Overview

4.2.3 Bayer Therapeutic Nuclear Medicines Products Offered

4.2.4 Bayer Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2017-2022)

4.2.5 Bayer Therapeutic Nuclear Medicines Sales by Product in 2021

4.2.6 Bayer Therapeutic Nuclear Medicines Sales by Application in 2021

4.2.7 Bayer Therapeutic Nuclear Medicines Sales by Geographic Area in 2021

4.2.8 Bayer Recent Developments

4.3 China Isotope & Radiation

4.3.1 China Isotope & Radiation Corporation Information

4.3.2 China Isotope & Radiation Description, Business Overview

4.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Products Offered

4.3.4 China Isotope & Radiation Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2017-2022)

4.3.5 China Isotope & Radiation Therapeutic Nuclear Medicines Sales by Product in 2021

4.3.6 China Isotope & Radiation Therapeutic Nuclear Medicines Sales by Application in 2021

4.3.7 China Isotope & Radiation Therapeutic Nuclear Medicines Sales by Geographic Area in 2021

4.3.8 China Isotope & Radiation Recent Developments

4.4 Q BioMed

4.4.1 Q BioMed Corporation Information

4.4.2 Q BioMed Description, Business Overview

4.4.3 Q BioMed Therapeutic Nuclear Medicines Products Offered

4.4.4 Q BioMed Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2017-2022)

4.4.5 Q BioMed Therapeutic Nuclear Medicines Sales by Product in 2021

4.4.6 Q BioMed Therapeutic Nuclear Medicines Sales by Application in 2021

4.4.7 Q BioMed Therapeutic Nuclear Medicines Sales by Geographic Area in 2021

4.4.8 Q BioMed Recent Developments

4.5 Curium Pharmaceuticals

4.5.1 Curium Pharmaceuticals Corporation Information

4.5.2 Curium Pharmaceuticals Description, Business Overview

4.5.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Products Offered

4.5.4 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2017-2022)

4.5.5 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales by Product in 2021

4.5.6 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales by Application in 2021

4.5.7 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales by Geographic Area in 2021

4.5.8 Curium Pharmaceuticals Recent Developments

4.6 Jubilant DraxImage

4.6.1 Jubilant DraxImage Corporation Information

4.6.2 Jubilant DraxImage Description, Business Overview

4.6.3 Jubilant DraxImage Therapeutic Nuclear Medicines Products Offered

4.6.4 Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2017-2022)

4.6.5 Jubilant DraxImage Therapeutic Nuclear Medicines Sales by Product in 2021

4.6.6 Jubilant DraxImage Therapeutic Nuclear Medicines Sales by Application in 2021

4.6.7 Jubilant DraxImage Therapeutic Nuclear Medicines Sales by Geographic Area in 2021

4.6.8 Jubilant DraxImage Recent Development

4.7 Dongcheng

4.7.1 Dongcheng Corporation Information

4.7.2 Dongcheng Description, Business Overview

4.7.3 Dongcheng Therapeutic Nuclear Medicines Products Offered

4.7.4 Dongcheng Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2017-2022)

4.7.5 Dongcheng Therapeutic Nuclear Medicines Sales by Product in 2021

4.7.6 Dongcheng Therapeutic Nuclear Medicines Sales by Application in 2021

4.7.7 Dongcheng Therapeutic Nuclear Medicines Sales by Geographic Area in 2021

4.7.8 Dongcheng Recent Development

4.8 Lantheus

4.8.1 Lantheus Corporation Information

4.8.2 Lantheus Description, Business Overview

4.8.3 Lantheus Therapeutic Nuclear Medicines Products Offered

4.8.4 Lantheus Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2017-2022)

4.8.5 Lantheus Therapeutic Nuclear Medicines Sales by Product in 2021

4.8.6 Lantheus Therapeutic Nuclear Medicines Sales by Application in 2021

4.8.7 Lantheus Therapeutic Nuclear Medicines Sales by Geographic Area in 2021

4.8.8 Lantheus Recent Development

4.9 Acrotech Biopharma.

4.9.1 Acrotech Biopharma. Corporation Information

4.9.2 Acrotech Biopharma. Description, Business Overview

4.9.3 Acrotech Biopharma. Therapeutic Nuclear Medicines Products Offered

4.9.4 Acrotech Biopharma. Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2017-2022)

4.9.5 Acrotech Biopharma. Therapeutic Nuclear Medicines Sales by Product in 2021

4.9.6 Acrotech Biopharma. Therapeutic Nuclear Medicines Sales by Application in 2021

4.9.7 Acrotech Biopharma. Therapeutic Nuclear Medicines Sales by Geographic Area in 2021

4.9.8 Acrotech Biopharma. Recent Development

4.10 Progenics Pharmaceuticals

4.10.1 Progenics Pharmaceuticals Corporation Information

4.10.2 Progenics Pharmaceuticals Description, Business Overview

4.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Products Offered

4.10.4 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2017-2022)

4.10.5 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales by Product in 2021

4.10.6 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales by Application in 2021

4.10.7 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales by Geographic Area in 2021

4.10.8 Progenics Pharmaceuticals Recent Development

4.11 International Isotopes

4.11.1 International Isotopes Corporation Information

4.11.2 International Isotopes Description, Business Overview

4.11.3 International Isotopes Therapeutic Nuclear Medicines Products Offered

4.11.4 International Isotopes Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2017-2022)

4.11.5 International Isotopes Therapeutic Nuclear Medicines Sales by Product in 2021

4.11.6 International Isotopes Therapeutic Nuclear Medicines Sales by Application in 2021

4.11.7 International Isotopes Therapeutic Nuclear Medicines Sales by Geographic Area in 2021

4.11.8 International Isotopes Recent Development

5.1 Global Therapeutic Nuclear Medicines Sales by Type (2017-2028)

5.1.1 Global Therapeutic Nuclear Medicines Sales by Type (2017-2022)

5.1.2 Global Therapeutic Nuclear Medicines Sales Forecast by Type (2023-2028)

5.1.3 Global Therapeutic Nuclear Medicines Sales Market Share by Type (2017-2028)

5.2 Global Therapeutic Nuclear Medicines Revenue Forecast by Type (2017-2028)

5.2.1 Global Therapeutic Nuclear Medicines Revenue by Type (2017-2022)

5.2.2 Global Therapeutic Nuclear Medicines Revenue Forecast by Type (2023-2028)

5.2.3 Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2017-2028)

5.3 Therapeutic Nuclear Medicines Average Selling Price (ASP) by Type (2017-2028)

6.1 Global Therapeutic Nuclear Medicines Sales by Application (2017-2028)

6.1.1 Global Therapeutic Nuclear Medicines Sales by Application (2017-2022)

6.1.2 Global Therapeutic Nuclear Medicines Sales Forecast by Application (2023-2028)

6.1.3 Global Therapeutic Nuclear Medicines Sales Market Share by Application (2017-2028)

6.2 Global Therapeutic Nuclear Medicines Revenue Forecast by Application (2017-2028)

6.2.1 Global Therapeutic Nuclear Medicines Revenue by Application (2017-2022)

6.2.2 Global Therapeutic Nuclear Medicines Revenue Forecast by Application (2023-2028)

6.2.3 Global Therapeutic Nuclear Medicines Revenue Market Share by Application (2017-2028)

6.3 Therapeutic Nuclear Medicines Average Selling Price (ASP) by Application (2017-2028)

7.1 North America Therapeutic Nuclear Medicines Market Size YoY Growth 2017-2028

7.2 North America Therapeutic Nuclear Medicines Market Facts & Figures by Country

7.2.1 North America Therapeutic Nuclear Medicines Sales by Country (2017-2028)

7.2.2 North America Therapeutic Nuclear Medicines Revenue by Country (2017-2028)

7.3 North America Therapeutic Nuclear Medicines Sales by Type

7.4 North America Therapeutic Nuclear Medicines Sales by Application

8.1 Asia-Pacific Therapeutic Nuclear Medicines Market Size YoY Growth 2017-2028

8.2 Asia-Pacific Therapeutic Nuclear Medicines Market Facts & Figures by Region

8.2.1 Asia-Pacific Therapeutic Nuclear Medicines Sales by Region (2017-2028)

8.2.2 Asia-Pacific Therapeutic Nuclear Medicines Revenue by Region (2017-2028)

8.3 Asia-Pacific Therapeutic Nuclear Medicines Sales by Type

8.4 Asia-Pacific Therapeutic Nuclear Medicines Sales by Application

9.1 Europe Therapeutic Nuclear Medicines Market Size YoY Growth 2017-2028

9.2 Europe Therapeutic Nuclear Medicines Market Facts & Figures by Country

9.2.1 Europe Therapeutic Nuclear Medicines Sales by Country (2017-2028)

9.2.2 Europe Therapeutic Nuclear Medicines Revenue by Country (2017-2028)

9.3 Europe Therapeutic Nuclear Medicines Sales by Type

9.4 Europe Therapeutic Nuclear Medicines Sales by Application

10.1 Latin America Therapeutic Nuclear Medicines Market Size YoY Growth 2017-2028

10.2 Latin America Therapeutic Nuclear Medicines Market Facts & Figures by Country

10.2.1 Latin America Therapeutic Nuclear Medicines Sales by Country (2017-2028)

10.2.2 Latin America Therapeutic Nuclear Medicines Revenue by Country (2017-2028)

10.3 Latin America Therapeutic Nuclear Medicines Sales by Type

10.4 Latin America Therapeutic Nuclear Medicines Sales by Application

11.1 Middle East and Africa Therapeutic Nuclear Medicines Market Size YoY Growth 2017-2028

11.2 Middle East and Africa Therapeutic Nuclear Medicines Market Facts & Figures by Country

11.2.1 Middle East and Africa Therapeutic Nuclear Medicines Sales by Country (2017-2028)

11.2.2 Middle East and Africa Therapeutic Nuclear Medicines Revenue by Country (2017-2028)

11.3 Middle East and Africa Therapeutic Nuclear Medicines Sales by Type

11.4 Middle East and Africa Therapeutic Nuclear Medicines Sales by Application

12.1 Therapeutic Nuclear Medicines Supply Chain Analysis

12.2 Therapeutic Nuclear Medicines Key Raw Materials and Upstream Suppliers

12.3 Therapeutic Nuclear Medicines Clients Analysis

12.4 Therapeutic Nuclear Medicines Sales Channel and Sales Model Analysis

12.4.1 Therapeutic Nuclear Medicines Distribution Channel Analysis: Indirect Sales VS Direct Sales

12.4.2 Therapeutic Nuclear Medicines Distribution Channel Analysis: Online Sales VS Offline Sales

12.4.3 Therapeutic Nuclear Medicines Distributors

13.1 Therapeutic Nuclear Medicines Industry Trends

13.2 Therapeutic Nuclear Medicines Market Drivers

13.3 Therapeutic Nuclear Medicines Market Challenges

13.4 Therapeutic Nuclear Medicines Market Restraints

13.5 Porter’s Five Forces Analysis

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

List of Tables

    Table 1. Global Therapeutic Nuclear Medicines Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028

    Table 2. Major Manufacturers of Radium-223

    Table 3. Major Manufacturers of Lutetium-177

    Table 4. Major Manufacturers of Iodine-131

    Table 5. Major Manufacturers of Other

    Table 6. Global Therapeutic Nuclear Medicines Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028

    Table 7. Global Therapeutic Nuclear Medicines Market Size by Region (US$ Million): 2021 VS 2022 VS 2028

    Table 8. Global Therapeutic Nuclear Medicines Sales by Region (2017-2022) & (K Units)

    Table 9. Global Therapeutic Nuclear Medicines Sales Forecast by Region (2023-2028) & (K Units)

    Table 10. Global Therapeutic Nuclear Medicines Revenue by Region (2017-2022) & (US$ Million)

    Table 11. Global Therapeutic Nuclear Medicines Revenue Forecast by Region (2023-2028) & (US$ Million)

    Table 12. Global Therapeutic Nuclear Medicines Sales by Manufacturer (2017-2022) & (K Units)

    Table 13. Global Therapeutic Nuclear Medicines Sales Share by Manufacturer (2017-2022)

    Table 14. Therapeutic Nuclear Medicines Revenue by Manufacturer (2017-2022) & (US$ Million)

    Table 15. Therapeutic Nuclear Medicines Revenue Share by Manufacturer (2017-2022)

    Table 16. Key Manufacturers Therapeutic Nuclear Medicines Price (2017-2022) & (USD/Unit)

    Table 17. Ranking of Global Top Therapeutic Nuclear Medicines Manufacturers by Revenue (US$ Million) in 2021

    Table 18. Global Therapeutic Nuclear Medicines Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)

    Table 19. Global Therapeutic Nuclear Medicines by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Therapeutic Nuclear Medicines as of 2021)

    Table 20. Therapeutic Nuclear Medicines Manufacturers Manufacturing Base Distribution and Headquarters

    Table 21. Manufacturers Therapeutic Nuclear Medicines Product Type

    Table 22. Date of International Manufacturers Enter into Therapeutic Nuclear Medicines Market

    Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 24. Novartis AG Corporation Information

    Table 25. Novartis AG Description and Business Overview

    Table 26. Novartis AG Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

    Table 27. Novartis AG Therapeutic Nuclear Medicines Product

    Table 28. Novartis AG Therapeutic Nuclear Medicines Sales Proportion of Therapeutic Nuclear Medicines by Product in 2021

    Table 29. Novartis AG Therapeutic Nuclear Medicines Sales Proportion of Therapeutic Nuclear Medicines by Application in 2021

    Table 30. Novartis AG Therapeutic Nuclear Medicines Sales Proportion of Therapeutic Nuclear Medicines by Geographic Area in 2021

    Table 31. Novartis AG Recent Development

    Table 32. Bayer Corporation Information

    Table 33. Bayer Description and Business Overview

    Table 34. Bayer Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

    Table 35. Bayer Therapeutic Nuclear Medicines Product

    Table 36. Bayer Therapeutic Nuclear Medicines Sales Proportion of Therapeutic Nuclear Medicines by Product in 2021

    Table 37. Bayer Therapeutic Nuclear Medicines Sales Proportion of Therapeutic Nuclear Medicines by Application in 2021

    Table 38. Bayer Therapeutic Nuclear Medicines Sales Proportion of Therapeutic Nuclear Medicines by Geographic Area in 2021

    Table 39. Bayer Recent Development

    Table 40. China Isotope & Radiation Corporation Information

    Table 41. China Isotope & Radiation Description and Business Overview

    Table 42. China Isotope & Radiation Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

    Table 43. China Isotope & Radiation Therapeutic Nuclear Medicines Product

    Table 44. China Isotope & Radiation Therapeutic Nuclear Medicines Sales Proportion of Therapeutic Nuclear Medicines by Product in 2021

    Table 45. China Isotope & Radiation Therapeutic Nuclear Medicines Sales Proportion of Therapeutic Nuclear Medicines by Application in 2021

    Table 46. China Isotope & Radiation Therapeutic Nuclear Medicines Sales Proportion of Therapeutic Nuclear Medicines by Geographic Area in 2021

    Table 47. China Isotope & Radiation Recent Development

    Table 48. Q BioMed Corporation Information

    Table 49. Q BioMed Description and Business Overview

    Table 50. Q BioMed Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

    Table 51. Q BioMed Therapeutic Nuclear Medicines Product

    Table 52. Q BioMed Therapeutic Nuclear Medicines Sales Proportion of Therapeutic Nuclear Medicines by Product in 2021

    Table 53. Q BioMed Therapeutic Nuclear Medicines Sales Proportion of Therapeutic Nuclear Medicines by Application in 2021

    Table 54. Q BioMed Therapeutic Nuclear Medicines Sales Proportion of Therapeutic Nuclear Medicines by Geographic Area in 2021

    Table 55. Q BioMed Recent Development

    Table 56. Curium Pharmaceuticals Corporation Information

    Table 57. Curium Pharmaceuticals Description and Business Overview

    Table 58. Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

    Table 59. Curium Pharmaceuticals Therapeutic Nuclear Medicines Product

    Table 60. Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales Proportion of Therapeutic Nuclear Medicines by Product in 2021

    Table 61. Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales Proportion of Therapeutic Nuclear Medicines by Application in 2021

    Table 62. Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales Proportion of Therapeutic Nuclear Medicines by Geographic Area in 2021

    Table 63. Curium Pharmaceuticals Recent Development

    Table 64. Jubilant DraxImage Corporation Information

    Table 65. Jubilant DraxImage Description and Business Overview

    Table 66. Jubilant DraxImage Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

    Table 67. Jubilant DraxImage Therapeutic Nuclear Medicines Product

    Table 68. Jubilant DraxImage Therapeutic Nuclear Medicines Sales Proportion of Therapeutic Nuclear Medicines by Product in 2021

    Table 69. Jubilant DraxImage Therapeutic Nuclear Medicines Sales Proportion of Therapeutic Nuclear Medicines by Application in 2021

    Table 70. Jubilant DraxImage Therapeutic Nuclear Medicines Sales Proportion of Therapeutic Nuclear Medicines by Geographic Area in 2021

    Table 71. Dongcheng Corporation Information

    Table 72. Dongcheng Description and Business Overview

    Table 73. Dongcheng Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

    Table 74. Dongcheng Therapeutic Nuclear Medicines Product

    Table 75. Dongcheng Therapeutic Nuclear Medicines Sales Proportion of Therapeutic Nuclear Medicines by Product in 2021

    Table 76. Dongcheng Therapeutic Nuclear Medicines Sales Proportion of Therapeutic Nuclear Medicines by Application in 2021

    Table 77. Dongcheng Therapeutic Nuclear Medicines Sales Proportion of Therapeutic Nuclear Medicines by Geographic Area in 2021

    Table 78. Lantheus Corporation Information

    Table 79. Lantheus Description and Business Overview

    Table 80. Lantheus Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

    Table 81. Lantheus Therapeutic Nuclear Medicines Product

    Table 82. Lantheus Therapeutic Nuclear Medicines Sales Proportion of Therapeutic Nuclear Medicines by Product in 2021

    Table 83. Lantheus Therapeutic Nuclear Medicines Sales Proportion of Therapeutic Nuclear Medicines by Application in 2021

    Table 84. Lantheus Therapeutic Nuclear Medicines Sales Proportion of Therapeutic Nuclear Medicines by Geographic Area in 2021

    Table 85. Acrotech Biopharma. Corporation Information

    Table 86. Acrotech Biopharma. Description and Business Overview

    Table 87. Acrotech Biopharma. Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

    Table 88. Acrotech Biopharma. Therapeutic Nuclear Medicines Product

    Table 89. Acrotech Biopharma. Therapeutic Nuclear Medicines Sales Proportion of Therapeutic Nuclear Medicines by Product in 2021

    Table 90. Acrotech Biopharma. Therapeutic Nuclear Medicines Sales Proportion of Therapeutic Nuclear Medicines by Application in 2021

    Table 91. Acrotech Biopharma. Therapeutic Nuclear Medicines Sales Proportion of Therapeutic Nuclear Medicines by Geographic Area in 2021

    Table 92. Progenics Pharmaceuticals Corporation Information

    Table 93. Progenics Pharmaceuticals Description and Business Overview

    Table 94. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

    Table 95. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product

    Table 96. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales Proportion of Therapeutic Nuclear Medicines by Product in 2021

    Table 97. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales Proportion of Therapeutic Nuclear Medicines by Application in 2021

    Table 98. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales Proportion of Therapeutic Nuclear Medicines by Geographic Area in 2021

    Table 99. International Isotopes Corporation Information

    Table 100. International Isotopes Description and Business Overview

    Table 101. International Isotopes Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

    Table 102. International Isotopes Therapeutic Nuclear Medicines Product

    Table 103. International Isotopes Therapeutic Nuclear Medicines Sales Proportion of Therapeutic Nuclear Medicines by Product in 2021

    Table 104. International Isotopes Therapeutic Nuclear Medicines Sales Proportion of Therapeutic Nuclear Medicines by Application in 2021

    Table 105. International Isotopes Therapeutic Nuclear Medicines Sales Proportion of Therapeutic Nuclear Medicines by Geographic Area in 2021

    Table 106. Global Therapeutic Nuclear Medicines Sales by Type (2017-2022) & (K Units)

    Table 107. Global Therapeutic Nuclear Medicines Sales Forecast by Type (2023-2028) & (K Units)

    Table 108. Global Therapeutic Nuclear Medicines Revenue by Type (2017-2022) & (US$ Million)

    Table 109. Global Therapeutic Nuclear Medicines Revenue Forecast by Type (2023-2028) & (US$ Million)

    Table 110. Global Therapeutic Nuclear Medicines Sales by Application (2017-2022) & (K Units)

    Table 111. Global Therapeutic Nuclear Medicines Sales Forecast by Application (2023-2028) & (K Units)

    Table 112. Global Therapeutic Nuclear Medicines Revenue by Application (2017-2022) & (US$ Million)

    Table 113. Global Therapeutic Nuclear Medicines Revenue Forecast by Application (2023-2028) & (US$ Million)

    Table 114. North America Therapeutic Nuclear Medicines Sales by Country (2017-2022) & (K Units)

    Table 115. North America Therapeutic Nuclear Medicines Sales by Country (2023-2028) & (K Units)

    Table 116. North America Therapeutic Nuclear Medicines Revenue by Country (2017-2022) & (US$ Million)

    Table 117. North America Therapeutic Nuclear Medicines Revenue by Country (2023-2028) & (US$ Million)

    Table 118. North America Therapeutic Nuclear Medicines Sales by Type (2017-2022) & (K Units)

    Table 119. North America Therapeutic Nuclear Medicines Sales by Application (2017-2022) & (K Units)

    Table 120. Asia-Pacific Therapeutic Nuclear Medicines Sales by Region (2017-2022) & (K Units)

    Table 121. Asia-Pacific Therapeutic Nuclear Medicines Sales by Region (2023-2028) & (K Units)

    Table 122. Asia-Pacific Therapeutic Nuclear Medicines Revenue by Region (2017-2028) & (US$ Million)

    Table 123. Asia-Pacific Therapeutic Nuclear Medicines Revenue by Region (2023-2028) & (US$ Million)

    Table 124. Asia-Pacific Therapeutic Nuclear Medicines Sales by Type (2017-2022) & (K Units)

    Table 125. Asia-Pacific Therapeutic Nuclear Medicines Sales by Application (2017-2022) & (K Units)

    Table 126. Europe Therapeutic Nuclear Medicines Sales by Country (2017-2022) & (K Units)

    Table 127. Europe Therapeutic Nuclear Medicines Sales by Country (2023-2028) & (K Units)

    Table 128. Europe Therapeutic Nuclear Medicines Revenue by Country (2017-2022) & (US$ Million)

    Table 129. Europe Therapeutic Nuclear Medicines Revenue by Country (2023-2028) & (US$ Million)

    Table 130. Europe Therapeutic Nuclear Medicines Sales by Type (2017-2022) & (K Units)

    Table 131. Europe Therapeutic Nuclear Medicines Sales by Application (2017-2022) & (K Units)

    Table 132. Latin America Therapeutic Nuclear Medicines Sales by Country (2017-2022) & (K Units)

    Table 133. Latin America Therapeutic Nuclear Medicines Sales by Country (2023-2028) & (K Units)

    Table 134. Latin America Therapeutic Nuclear Medicines Revenue by Country (2017-2022) & (US$ Million)

    Table 135. Latin America Therapeutic Nuclear Medicines Revenue by Country (2023-2028) & (US$ Million)

    Table 136. Latin America Therapeutic Nuclear Medicines Sales by Type (2017-2022) & (K Units)

    Table 137. Latin America Therapeutic Nuclear Medicines Sales by Application (2017-2022) & (K Units)

    Table 138. Middle East and Africa Therapeutic Nuclear Medicines Sales by Country (2017-2022) & (K Units)

    Table 139. Middle East and Africa Therapeutic Nuclear Medicines Sales by Country (2023-2028) & (K Units)

    Table 140. Middle East and Africa Therapeutic Nuclear Medicines Revenue by Country (2017-2022) & (US$ Million)

    Table 141. Middle East and Africa Therapeutic Nuclear Medicines Revenue by Country (2023-2028) & (US$ Million)

    Table 142. Middle East and Africa Therapeutic Nuclear Medicines Sales by Type (2017-2022) & (K Units)

    Table 143. Middle East and Africa Therapeutic Nuclear Medicines Sales by Application (2017-2022) & (K Units)

    Table 144. Therapeutic Nuclear Medicines Key Raw Materials, Industry Status and Trend

    Table 145. Therapeutic Nuclear Medicines Key Raw Materials and Upstream Suppliers

    Table 146. Therapeutic Nuclear Medicines Clients Status and Trend

    Table 147. Therapeutic Nuclear Medicines Typical Clients

    Table 148. Therapeutic Nuclear Medicines Distributors

    Table 149. Therapeutic Nuclear Medicines Market Trends

    Table 150. Therapeutic Nuclear Medicines Market Drivers

    Table 151. Therapeutic Nuclear Medicines Market Challenges

    Table 152. Therapeutic Nuclear Medicines Market Restraints

    Table 153. Research Programs/Design for This Report

    Table 154. Key Data Information from Secondary Sources

    Table 155. Key Data Information from Primary Sources

List of Figures

    Figure 1. Therapeutic Nuclear Medicines Product Picture

    Figure 2. Global Therapeutic Nuclear Medicines Sales Market Share by Type in 2021 & 2028

    Figure 3. Radium-223 Product Picture

    Figure 4. Lutetium-177 Product Picture

    Figure 5. Iodine-131 Product Picture

    Figure 6. Other Product Picture

    Figure 7. Global Therapeutic Nuclear Medicines Sales Market Share by Application in 2021 & 2028

    Figure 8. Thyroid Examples

    Figure 9. Bone Metastasis Examples

    Figure 10. Lymphoma Examples

    Figure 11. Other Examples

    Figure 12. Therapeutic Nuclear Medicines Report Years Considered

    Figure 13. Global Therapeutic Nuclear Medicines Market Size, (US$ Million), 2017 VS 2021 VS 2028

    Figure 14. Global Therapeutic Nuclear Medicines Market Size 2017-2028 (US$ Million)

    Figure 15. Global Therapeutic Nuclear Medicines Sales 2017-2028 (K Units)

    Figure 16. Global Therapeutic Nuclear Medicines Market Size Market Share by Region: 2022 Versus 2028

    Figure 17. Global Therapeutic Nuclear Medicines Sales Market Share Forecast by Region (2017-2028)

    Figure 18. Global Therapeutic Nuclear Medicines Revenue Market Share by Region (2017-2028)

    Figure 19. Global Therapeutic Nuclear Medicines Sales Share by Manufacturer in 2021

    Figure 20. Therapeutic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021

    Figure 21. Global Therapeutic Nuclear Medicines Sales Market Share Forecast by Type (2017-2028)

    Figure 22. Global Therapeutic Nuclear Medicines Revenue Market Share Forecast by Type (2017-2028)

    Figure 23. Therapeutic Nuclear Medicines Average Selling Price (ASP) by Type (2017-2022) & (USD/Unit)

    Figure 24. Global Therapeutic Nuclear Medicines Sales Market Share Forecast by Application (2017-2028)

    Figure 25. Global Therapeutic Nuclear Medicines Revenue Market Share Forecast by Application (2017-2028)

    Figure 26. Therapeutic Nuclear Medicines Average Selling Price (ASP) by Application (2017-2022) & (USD/Unit)

    Figure 27. North America Therapeutic Nuclear Medicines Revenue 2017-2028 (US$ Million)

    Figure 28. North America Therapeutic Nuclear Medicines Sales Market Share by Type (2017-2022)

    Figure 29. North America Therapeutic Nuclear Medicines Sales Market Share by Application (2017-2022)

    Figure 30. Asia-Pacific Therapeutic Nuclear Medicines Revenue 2017-2028 (US$ Million)

    Figure 31. Asia-Pacific Therapeutic Nuclear Medicines Sales Market Share by Region (2017-2028)

    Figure 32. Asia-Pacific Therapeutic Nuclear Medicines Revenue Market Share by Region (2017-2028)

    Figure 33. Asia-Pacific Therapeutic Nuclear Medicines Sales Market Share by Type (2017-2022)

    Figure 34. Asia-Pacific Therapeutic Nuclear Medicines Sales Market Share by Application (2017-2022)

    Figure 35. Europe Therapeutic Nuclear Medicines Revenue Growth Rate 2017-2028 (US$ Million)

    Figure 36. Europe Therapeutic Nuclear Medicines Sales Market Share by Country (2017-2028)

    Figure 37. Europe Therapeutic Nuclear Medicines Revenue Market Share by Country (2017-2028)

    Figure 38. Europe Therapeutic Nuclear Medicines Sales Market Share by Type (2017-2022)

    Figure 39. Europe Therapeutic Nuclear Medicines Sales Market Share by Application (2017-2022)

    Figure 40. Latin America Therapeutic Nuclear Medicines Revenue Growth Rate 2017-2028 (US$ Million)

    Figure 41. Latin America Therapeutic Nuclear Medicines Sales Market Share by Country (2017-2028)

    Figure 42. Latin America Therapeutic Nuclear Medicines Revenue Market Share by Country (2017-2022)

    Figure 43. Latin America Therapeutic Nuclear Medicines Sales Market Share by Type (2017-2022)

    Figure 44. Latin America Therapeutic Nuclear Medicines Sales Market Share by Application (2017-2022)

    Figure 45. Middle East and Africa Therapeutic Nuclear Medicines Revenue Growth Rate 2017-2028 (US$ Million)

    Figure 46. Middle East and Africa Therapeutic Nuclear Medicines Sales Market Share by Country (2017-2028)

    Figure 47. Middle East and Africa Therapeutic Nuclear Medicines Revenue Market Share by Country (2017-2028)

    Figure 48. Middle East and Africa Therapeutic Nuclear Medicines Sales Market Share by Type (2017-2022)

    Figure 49. Middle East and Africa Therapeutic Nuclear Medicines Sales Market Share by Application (2017-2022)

    Figure 50. Therapeutic Nuclear Medicines Supply Chain (Upstream and Downstream Market)

    Figure 51. Global Production Market Share of Therapeutic Nuclear Medicines Raw Materials by Region in 2021

    Figure 52. Therapeutic Nuclear Medicines Distribution Channels

    Figure 53. Global Therapeutic Nuclear Medicines Percentage 2017-2028: Indirect Sales VS Direct Sales

    Figure 54. Global Therapeutic Nuclear Medicines Percentage 2017-2028: Online Sales VS Offline Sales

    Figure 55. Bottom-up and Top-down Approaches for This Report

    Figure 56. Data Triangulation